polypodium leucotomos
Botanicalexperimental
Phlebodium aureum is an epiphytic fern native to tropical and subtropical regions of the Americas. — Wikipedia
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2007 (NCT00520910)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaPhlebodium aureum ↗
Also known as
- polypodium leucotomos
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02813902 | Phase 1 | Jul 1, 2016 | Harvard University |
| NCT02904798 | N/A | Jul 1, 2015 | Henry Ford Health System |
| NCT01162850 | N/A | May 1, 2008 | University of Miami |
| NCT00520910 | Phase 2 | Aug 1, 2007 | University of Miami |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Miami | Academic/Hospital | 2 | 2 | 2 | 2007 |
| Harvard University | Academic/Hospital | 1 | 1 | 1 | 2016 |
| Henry Ford Health System | Academic/Hospital | 1 | 1 | 1 | 2015 |
3 organizations
Page 1 / 1